Primitive neuroectodermal tumour

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase I: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I

1 trial
  • Prinses Maxima Centrum voor Kinderoncologie B.V. Academic
    4-((2,4-DIFLUOROPHENYL)METHYL)2,4,6,7,8,9-HEXAHYDRO-7(PHENYLMETHYL)IMIDAZO(1,2-A)PYRIDO(3,4-E)PYRIMIDIN-5(1H)-ONE
    2025-521180-13-00 1 country 2026 n=20
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Prinses Maxima Centrum voor Kinderoncologie B.V. Academic 1 Phase I 1
New trials by year
2026
1
← All indication landscapes